Clinical trial
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients With Xeroderma Pigmentosum C and V (XPC and XPV)
NCT05370235 is registered in ClinicalTrials.gov with Clinuvel Europe Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients With Xeroderma Pigmentosum C and V (XPC and XPV)
- Lead sponsor
- Clinuvel Europe Limited
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 28, 2022
- Completion date
- December 31, 2024
- Enrollment
- 6 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.